Duolingo vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 28)

Duolingo

EmergingEducation

General

Pittsburgh gamified language learning (NASDAQ: DUOL, $17.7B market cap); Q3 2025 $400.2M revenue with 47.7M DAU +40% YoY and 2025 guidance raised to $1.68B; Chess course 1M+ DAU competing with Babbel for consumer language EdTech.

AI VisibilityBeta
Overall Score
D28
Category Rank
#814 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
32
Perplexity
23
Gemini
27

About

Duolingo is a Pittsburgh, Pennsylvania-based language learning platform — publicly traded on NASDAQ (NASDAQ: DUOL) at approximately $17.7 billion market capitalization as of mid-2025 — providing 130+ million monthly active users with gamified language and education courses in 42 languages plus mathematics, music, and chess. In Q3 2025, Duolingo reported $400.2 million in revenue (+9% year-over-year), 47.7 million daily active users (+40% YoY), and 10.9 million paid subscribers (+37% YoY), raising full-year 2025 guidance to $1.68-1.69 billion — versus $748 million in 2024 revenue. The Chess course launched in 2025 surpassed 1 million daily users. Duolingo Max and Super Duolingo premium subscriptions provide AI-powered features including GPT-4-powered conversational practice (Duolingo Max) with roleplay scenarios and AI explanations. Duolingo employs 800+ people with >90% annual employee retention. Founded 2011 by Carnegie Mellon professor Luis von Ahn and Severin Hacker; NASDAQ IPO July 2021 at $3.7 billion valuation.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

28
Overall Score
90
#814
Category Rank
#9
67
AI Consensus
60
stable
Trend
stable
32
ChatGPT
99
23
Perplexity
99
27
Gemini
83
26
Claude
96
37
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.